ArticleInternational journal of chronic obstructive pulmonary disease2026
Exosomal miR-2110 from PM2.5-Exposed Lung Epithelial Cells Targets SRSF1 to Promote M1 Macrophage Polarization and Inflammatory Responses in COPD.
Article in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Exposure to PM2.5 is a known contributor to the development of chronic obstructive pulmonary disease (COPD). As direct targets of PM2.5, bronchial epithelial cells participate in intercellular communication with macrophages and induce phenotypic changes in these immune cells. This study aimed to investigate the role and underly mechanism of epithelial cell-derived exosomes in regulating macrophage polarization. Methods: Following PM2.5 exposure, exosomes were isolated from BEAS-2B cells and subsequently co-cultured with M0 macrophages. We measured the production of inflammatory cytokines and macrophage markers. The phenotypic effect of miR-2110 on macrophage polarization was examined in a COPD murine model, with subsequent exploration of relevant molecular pathways. The binding specificity of miR-2110 was assessed utilizing a luciferase reporter assay. Results: In vitro analyses confirmed that P-Exo (PM2.5-exposed BEAS-2B cells exosomes) triggered M1 polarization, as evidenced by elevated expression of IL-6, TNF-α, and iNOS-2. Additionally, miR-2110 expression was upregulated in P-Exo. Inhibition of miR-2110 reduced M1 polarization and decreased inflammatory cytokine production both in vitro and in vivo. Luciferase assays confirmed that miR-2110 targeted SRSF1 expression. Overexpression of SRSF1 mitigated the regulatory role of miR-2110 in promoting M1 phenotype transition and pro-inflammatory cytokine production. Conclusion: This work clarifies that exosomal miR-2110, which is produced from lung epithelial cells treated with PM2.5, exacerbates COPD and might be a viable target for COPD prevention and therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.